Streetbeat News

Products Services

META

Meta Platforms Inc's new social media platform, Threads, has seen 30 million sign-ups since its launch on July 6. Despite this, it still falls short of Twitter's 400 million users. However, Twitter's user base is predicted to fall by 32 million over the next few years following changes made by Elon Musk. Meta may have an advantage in India, where it has a large Instagram user base and Twitter has less impact. If every Indian Instagram user joined Threads, it would rival Twitter's user base.

Portfolio Pulse from Arpit Nayak

July 07, 2023 | 12:47 pm

BCLI

BrainStorm Cell Therapeutics Inc (NASDAQ:BCLI) presented new biomarker data from the Phase 3 trial of its ALS treatment, NurOwn, showing significant elevation in markers of neuroprotection and reduction in markers of neuroinflammation and neurodegeneration. Statistical modeling identified three biomarkers that predict clinical outcomes with NurOwn treatment. Despite this, BCLI shares fell by 4.50% in the premarket session.

Portfolio Pulse from Vandana Singh

July 07, 2023 | 12:34 pm

ONDS

Ondas Holdings Inc. (NASDAQ:ONDS) announced that its subsidiary Airobotics has signed an annual service agreement for the ongoing maintenance of the Optimus Systems operated by a local government entity in Dubai, UAE. The Optimus Systems, part of an urban drone infrastructure solution, have been extensively utilized for public safety and emergency response applications. Airobotics expects the Optimus Urban Drone Infrastructure to be widely deployed across Dubai and grow to more than 20 systems over the next few years.

Portfolio Pulse from Happy Mohamed

July 07, 2023 | 12:32 pm

EWC

EWG

EWQ

EWW

FXI

TSLA

Tesla has announced that it is offering a 'Refer and Earn' discount in several markets including China, Germany, Mexico, Canada, France, Singapore, and Hong Kong.

Portfolio Pulse from Happy Mohamed

July 07, 2023 | 12:29 pm

EWU

TSLA

Tesla has announced that starting July 7, new Model 3 or Model Y buyers in the UK will receive a £500 discount if they order using a referral link. Similarly, new Model S or Model X buyers will receive a £1,000 discount if they order using a referral link.

Portfolio Pulse from Happy Mohamed

July 07, 2023 | 12:29 pm

FXI

TSLA

Tesla has announced that starting July 7, new Model 3 or Model Y buyers in Hong Kong will receive a HK$4,000 discount on their purchase price if they order using a referral link.

Portfolio Pulse from Happy Mohamed

July 07, 2023 | 12:28 pm

TSLA

Tesla has announced that starting July 6, U.S. buyers of new Model 3 or Model Y will receive $500 off the purchase price. Additionally, they will receive 3 months of full self-driving capability if they order using a referral link. The person referring will receive 10,000 referral credits.

Portfolio Pulse from Happy Mohamed

July 07, 2023 | 12:21 pm

ESPR

Esperion (NASDAQ:ESPR) will present additional data from the CLEAR Outcomes study on cardiovascular disease (CVD) prevention at the 2023 American Society for Preventive Cardiology Congress. The presentation will focus on the use of ezetimibe among participants in the trial.

Portfolio Pulse from Happy Mohamed

July 07, 2023 | 12:03 pm

TSLA

Tesla Inc (NASDAQ:TSLA) has announced a reward of 3,500 yuan ($484) for Model Y and Model 3 buyers in China with a referral, along with 90 days of free access to the company’s enhanced autopilot system. This comes a day after Tesla pledged to avoid abnormal pricing in China. During Q2, over 53% of Tesla's global sales were made in China. Tesla, along with BYD and 14 other companies, signed a letter expressing a commitment to fair competition and the promotion of core socialist values in the Chinese auto market.

Portfolio Pulse from Anan Ashraf

July 07, 2023 | 12:02 pm

ZVSA

ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) has been granted a patent by the European Patent Office for its Phase 2a-ready Cholesterol Efflux Mediator VAR 200 for use in diabetic nephropathy/diabetic kidney disease. This development could potentially strengthen ZyVersa's position in the biopharmaceutical market.

Portfolio Pulse from Benzinga Newsdesk

July 07, 2023 | 11:39 am